UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046989
Receipt number R000051113
Scientific Title Effect of bilateral compression maneuver after esophagectomy for esophageal carcinoma.
Date of disclosure of the study information 2022/04/01
Last modified on 2024/02/26 10:14:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of bilateral compression maneuver after esophagectomy for esophageal carcinoma.

Acronym

Cough assist method after esophagectomy for esophageal carcinoma.

Scientific Title

Effect of bilateral compression maneuver after esophagectomy for esophageal carcinoma.

Scientific Title:Acronym

Bilateral compression maneuver after esophagectomy for esophageal carcinoma.

Region

Japan


Condition

Condition

Esophageal carcinoma

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect of bilateral abdominal compression maneuver

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Pain score on postoperative day 1, 3, 5 and 7.

Key secondary outcomes

a quality measure of multidimensional scale recovery, recovery rate of peak cough flow, and vital capacity ,on postoperative day 1, 3, 5 and 7.
Relationship between bilateral abdominal compression maneuver and age, gender, surgical procedure (presence or absence of cervical dissection, thoracotomy / non-thoracotomy, laparotomy / laparoscope), wound size, type of postoperative analgesia, dosage and administration of analgesia, past history, ICU admission period, postoperative hospitalization period , postoperative respiratory complications


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Behavior,custom Maneuver

Interventions/Control_1

Evaluate the pain score on coughing and respiratory function with the bilateral flank compression maneuver.

Interventions/Control_2

Evaluate the pain score on coughing and respiratory function with the thoracic compression maneuver

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients who undergo esophagectomy for esophageal carcinoma.
The patients consent from the person who has been obtained before the study registration in writing.

Key exclusion criteria

The patient who undergo emergency operation.
The patients who cannot compress their bilateral flank or thorax (e.g., heavily sedated or physically restrained).
The patients who are unable to assess pain due to sedation, dementia or psychosis.
The patients who refuse to the study.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Ueno
Middle name
Last name Masaki

Organization

Toranomon hospital

Division name

Gastroenterological surgery

Zip code

1058470

Address

2-2-2 Toranomon, Minato-ku, Tokyo

TEL

03-3588-1111

Email

ueno@toranomo.gr.jp


Public contact

Name of contact person

1st name Shimoyama
Middle name
Last name Hayato

Organization

Toranomon hospital

Division name

Gastroenterological surgery

Zip code

1058470

Address

2-2-2 Toranomon, Minato-ku, Tokyo

TEL

03-3588-1111

Homepage URL


Email

hayatos0124@gmail.com


Sponsor or person

Institute

Toranomon hospital

Institute

Department

Personal name



Funding Source

Organization

Toranomon hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Toranomon hospital, Department of Clinical Trial and Research

Address

2-2-2 Toranomon, Minato-ku, Tokyo

Tel

03-3588-1111

Email

chiken-jim2@toranomon.gr.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

虎の門病院


Other administrative information

Date of disclosure of the study information

2022 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2021 Year 07 Month 14 Day

Date of IRB

2021 Year 07 Month 27 Day

Anticipated trial start date

2022 Year 02 Month 25 Day

Last follow-up date

2024 Year 10 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 02 Month 24 Day

Last modified on

2024 Year 02 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051113